Skip to Main Content

Skip Nav Destination

Article navigation

Editorials| November 01 1957

What the Patient Should be Told About the Oral Hypoglycemic Compounds

Garfield G Duncan, M.D.

Garfield G Duncan, M.D.

Philadelphia, Pennsylvania

Search for other works by this author on:

PubMed

Google Scholar

Diabetes 1957;6(6):534–535

https://doi.org/10.2337/diab.6.6.534

PubMed:

13473649